Morgan Stanley’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $80.6M | Sell |
|
|||||
|
2025
Q2 | $60.5M | Buy |
|
|||||
|
2025
Q1 | $60M | Sell |
|
|||||
|
2024
Q4 | $59.1M | Buy |
|
|||||
|
2024
Q3 | $35.2M | Sell |
|
|||||
|
2024
Q2 | $36.9M | Sell |
|
|||||
|
2024
Q1 | $39.7M | Sell |
|
|||||
|
2023
Q4 | $39.3M | Buy |
|
|||||
|
2023
Q3 | $1.18M | Sell |
|
|||||
|
2023
Q2 | $4.63M | Buy |
|
|||||
|
2023
Q1 | $3.71M | Buy |
|
|||||
|
2022
Q4 | $2.93M | Buy |
|
|||||
|
2022
Q3 | $2.39M | Buy |
|
|||||
|
2022
Q2 | $2.3M | Buy |
|
|||||
|
2022
Q1 | $1.88M | Buy |
|
|||||
|
2021
Q4 | $1.1M | Sell |
|
|||||
|
2021
Q3 | $3.43M | Sell |
|
|||||
|
2021
Q2 | $6.18M | Buy |
|
|||||
|
2021
Q1 | $3.64M | Sell |
|
|||||
|
2020
Q4 | $4.28M | Buy |
|
|||||
|
2020
Q3 | $83K | Sell |
|
|||||
|
2020
Q2 | $108K | Buy |
|
|||||
|
2020
Q1 | $43K | Buy |
|